Interestingly, in a cisplatin-resistant human ovarian cancer cell line, KRT1 showed significant differential expression in proteomic analysis [9], and another study revealed that KRT1 may be associated with chemotherapy sensitivity in nasopharyngeal cancer [10]. This evidence concerns the gene KRT1 and ovarian cancer.